FIELD: veterinary science.
SUBSTANCE: invention relates to versions of porcine granulocyte colony-stimulating factor (pG-CSF) and use thereof.
EFFECT: versions of pG-CSF can be used for treating mastitis syndrome, metritis and agalactia (MMA) in a pig, treating a bacterial infection in a sow in the perinatal period, increasing the level of neutrophils in a sow in the perinatal period or reducing mortality in piglets.
37 cl, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| METHODS AND PRODUCTS FOR PRODUCING AND DELIVERING NUCLEIC ACIDS | 2015 |
|
RU2714404C2 |
| CD8A-BINDING DOMAINS OF III FIBRONECTIN TYPE | 2017 |
|
RU2759952C2 |
| STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION | 2016 |
|
RU2740672C2 |
| ANTI-HLA-A2 ANTIBODIES AND THEIR APPLICATION METHODS | 2018 |
|
RU2782276C2 |
| PORCINE TRYPSIN OPTIONS | 2019 |
|
RU2783315C2 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
| OPTIONS, COMPOSITIONS, AND METHODS FOR USE OF ENDONUCLEASE CBLB | 2018 |
|
RU2779097C2 |
| ANTI-TIGIT ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732591C2 |
| ANTI-HUMAN ANGIOPOIETIN-LIKE 4 PROTEIN ANTIBODIES | 2010 |
|
RU2580045C2 |
